Memorial Sloan Kettering Cancer Center shared a post on LinkedIn:
“Congratulations to Dr. Kenneth Offit, Chief of the Clinical Genetics Service at Memorial Sloan Kettering Cancer Center (MSK), and Ross Levine, Chief Scientific Officer at MSK, on their election to the Fellows of the American Association for Cancer Research (AACR) Academy. This election to the AACR Academy recognizes extraordinary scientists whose work has made a profound and lasting impact on cancer research.
Dr. Offit was elected for trailblazing research in hereditary cancer genetics, including the discovery of BRCA2 mutations in Ashkenazi Jewish populations, which led to the first genome-wide association study linking BRCA2 to breast cancer risk.
Dr. Levine was elected for groundbreaking contributions to defining the molecular biology of myeloid malignancies, including the discovery of key driver mutations, characterization of oncogenic signaling pathways such as JAK-STAT, and investigation of epigenetic mechanisms that influence disease progression in myeloproliferative neoplasms (MPN) and acute myeloid leukemia (AML).”
Read more from MSKCC on OncoDaily.